Effect of Pemafibrate on the Lipid Profile, Liver Function, and Liver Fibrosis Among Patients With Metabolic Dysfunction-Associated Steatotic Liver Disease Article (Web of Science)

cited authors

  • Hassan, Mona; Al-Obaidi, Hasan; Karrick, Megan; Merza, Nooraldin; Nawras, Yusuf; Saab, Omar; Al-Obaidi, Ahmed Dheyaa; Merza, Fatima; Hashim, Hashim Talib; Al Zubaidi, Khalid; Al-Sabbagh, Daniah; Matbachi, Rand; Noori, Zainab; Amatul-Raheem, Hajra; Mansur, Sarmad; Al Najafi, Omer; Algodi, Marwah; Al Hamdany, Tamarah; Kobeissy, Abdallah

publication date

  • August 1, 2024

webpage

published in

category

keywords

  • Lipid profile
  • Liver fibrosis
  • Liver stiffness
  • MASH
  • MASLD
  • PPAR
  • Pemafibrate

start page

  • 159

end page

  • 174

volume

  • 17

issue

  • 4